about
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivityThe SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cellsSafety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.A polymorphism at IGF1 locus is associated with anemia.Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals.Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells.3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients.The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivityDiverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetesThe GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes.PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases.Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials.Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells.Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects.SRT1720 counteracts glucosamine-induced endoplasmic reticulum stress and endothelial dysfunction.Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I.One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells.Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.Insulin-like growth factor-1 is a negative modulator of glucagon secretion.Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells.Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase.TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion.Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects.Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients.Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria.Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects.Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-ceA polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation.
P50
Q28730293-89A793E0-160C-4845-8760-959624D54248Q30010239-3EDA52B1-02DF-4CFC-A25A-E027E38345B7Q31167862-0D662CC7-EB41-42BA-AF0C-0E268E8909F7Q33584606-55E3775A-A29A-42D9-9099-54CF1D35B2FEQ33779097-6EA0B003-329B-4D86-AC29-CF7FA04C32B0Q33821921-4E678B14-E0A7-42D2-9A72-D0A12C234DB9Q33965156-13EBFBFA-D51B-45C3-B9FB-C0788CF08609Q34440283-EF3A637B-DEC4-4B1A-8CA1-0E36D5083D3DQ34949818-24EAA339-9325-4312-B920-7CB95638A199Q35083149-9B3970E6-2A22-419B-B02A-32271D9CE6F9Q35620125-DBCCA753-2A34-4B5F-BAF5-694DDB64F88EQ35676254-3AAC2B79-B1D4-4A17-BE90-459E9BB17230Q36915682-B68ABCD5-AEBC-4EDA-B8D1-B07B2D7B0339Q37072688-4015A6FD-F0B1-4C15-AD62-FD996AA44CA8Q37139985-E8BB004F-C718-4ACF-B8E5-C614319AC8B4Q37382378-4EE61C1B-FDEA-4EBE-B25E-464983837B11Q38664551-DA7EF795-4B54-446B-882E-BE10BC8FBB85Q38676310-2265B4C0-598E-4860-886C-3E7D0A7236BFQ38837644-77947A7E-121C-45EF-B329-CFD76F0D74F5Q38963523-14BA8104-E157-4FF6-9D11-DDA3544BDCC6Q38999901-201E5885-CEC8-49ED-8881-E6ECEB0C02F0Q39494990-57F15BDE-5DF3-4AC2-90FC-AFDF0ABDFE79Q39558973-56CBF901-2DF5-4A49-82A0-3CC0503B35F9Q39565163-1C8CD97F-7A81-454C-AA65-B4FC430AAD9CQ39737939-9D1C0E94-8EE7-4667-B792-D59D8B8DFB30Q39862194-BE522EC7-E4DE-4880-9BF9-BF7ED6DAE230Q40448775-1C9BF4EA-6BB7-4520-A242-3E2BE59249FAQ41612986-BF7610A7-1DCE-461A-9BD3-71F2A3730812Q42437129-40A10596-04F3-4939-8647-6EEF2C292A8FQ42475481-331DBA13-18D2-4E68-BB3D-FADEA8F97BF2Q42801345-C9854F48-F267-48FA-8930-535ED7AB902AQ43098902-68B64799-FAA5-48D6-AB47-74D458912844Q43113023-19267835-699A-4958-B6FA-419E65008571Q43421825-9458ADD5-934B-4E29-B055-9F48794335B5Q43524361-015D5715-5B05-4836-9A8A-41E08B028FEFQ43807641-2232866C-677D-4704-BBA0-9D7784180BEDQ43908707-5480643D-7744-47C6-BD46-40444B3B9CCFQ44134860-49E1EAB2-1B7B-4FCF-B9A4-FF2E8DA81B6EQ44786873-E1DE1C23-CD0D-4C3F-B247-8D70ED497B53Q44812668-30E7556D-790E-43C4-82CB-EC0106A590C2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesco Andreozzi
@ast
Francesco Andreozzi
@en
Francesco Andreozzi
@es
Francesco Andreozzi
@nl
Francesco Andreozzi
@sl
type
label
Francesco Andreozzi
@ast
Francesco Andreozzi
@en
Francesco Andreozzi
@es
Francesco Andreozzi
@nl
Francesco Andreozzi
@sl
prefLabel
Francesco Andreozzi
@ast
Francesco Andreozzi
@en
Francesco Andreozzi
@es
Francesco Andreozzi
@nl
Francesco Andreozzi
@sl
P1053
J-4073-2018
P106
P1153
6701547195
P21
P31
P3829
P496
0000-0001-9375-1513